Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
- PMID: 23094122
- PMCID: PMC3469852
- DOI: 10.3802/jgo.2012.23.4.207
Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?
Conflict of interest statement
No potential conflict of interests relevant to this article was reported.
Comment on
- J Gynecol Oncol. 23:226.
References
-
- Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535–540. - PubMed
-
- Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872–880. - PubMed
-
- Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28:2108–2113. - PubMed
-
- Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. Int J Radiat Oncol Biol Phys. 2004;60:1144–1153. - PubMed